If you’re going to make a movie about fighters, you can’t skimp on the details. So says Talia Shire, an actress who knows a thing or two about the genre. “You notice everything,” Shire said during an ...

When asked during a recent interview if she had any addictions, actress Jennifer Aniston admitted to just one: eye drops. That sounded familiar to Shire ($SHPG) execs ...

Shire nabbed FDA approval for its new long-acting ADHD drug, becoming the second drugmaker in two days to win a nod in that field. Shire’s drug, Mydayis, has been a long time coming. Previously known ...

The rumors that Teva might attempt to buy Shire are puzzling because such an acquisition would present a huge internal conflict to the combined company: What to do with Shire's Vyvanse and Adderall XR ...

Shire PLC is buying NPS Pharmaceuticals Inc., a maker of treatments for rare diseases, for $5.2 billion, returning to deal-making with the help of the breakup fee it received from one-time suitor ...

After six months of relentless pursuit, Shire SHPG finally announced that it will acquire Baxalta, Inc. BXLT for $32 billion. The boards of directors of both companies have agreed to the merger. We ...